DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Europe Parkinson's Disease Epidemiology and Patient Flow Analysis - 2017" report to their offering.
The report provides insights into Parkinson's Disease epidemiology, Parkinson's Disease diagnosed patients, and Parkinson's Disease treatment rate for EU5 pharmaceutical markets.
The study measures key indicators such as prevalence of Parkinson's Disease derived from epidemiological analysis, percentage of patients diagnosed with Parkinson's Disease, and percentage of patients treated with a therapy.
The study helps executives estimate Parkinson's Disease market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
The report provides estimates and forecasts of Parkinson's Disease prevalence, Parkinson's Disease diagnosis rate, and Parkinson's Disease treatment rate for the period 2016 - 2025.
Key Features of the Report:
- Parkinson's Disease Patient Flow
- Parkinson's Disease Prevalence
- Parkinson's Disease Diagnosed Patients
- Parkinson's Disease Treated Patients
Key Topics Covered:
1. Parkinson's Disease: Disease Definition
2. Parkinson's Disease Patient Flow in Europe
3. Parkinson's Disease Patient Flow in Germany
4. Parkinson's Disease Patient Flow in France
5. Parkinson's Disease Patient Flow in Spain
6. Parkinson's Disease Patient Flow in Italy
7. Parkinson's Disease Patient Flow in UK
For more information about this report visit http://www.researchandmarkets.com/research/fml35d/europe
